by Brian Cardillo | Jan 14, 2025 | News, Press Releases
WASHINGTON, D.C., JANUARY 14, 2025 – This morning, ATA Action urged the Drug Enforcement Agency (DEA) to take immediate steps to form a public-private workgroup to establish a permanent framework for the remote prescribing of controlled substances. In a letter to DEA...
by Allison Kavanagh | Jan 13, 2025 | News, Press Releases
WASHINGTON, D.C., JANUARY 13, 2025 – With critical telehealth flexibilities set to expire on March 31, 2025, and key provisions already lapsed as of December 31, 2024, urgent action is needed to prevent millions of patients from losing access to essential virtual care...
by Brian Cardillo | Dec 21, 2024 | News, Press Releases
Medicare telehealth flexibilities and the Acute Hospital Care at Home Program Extensions through March 2025 WASHINGTON, D.C., DECEMBER 21, 2024 – The American Telemedicine Association (ATA) and ATA Action respond to passage of a slimmed-down, short-term Continuing...
by Allison Kavanagh | Dec 17, 2024 | News, Press Releases
WASHINGTON, D.C., DECEMBER 17, 2024 – The American Telemedicine Association (ATA) and ATA Action cheer the just-announced legislative end-of-year Continuing Resolution (CR) that includes muti-year extensions for critically-needed telehealth flexibilities. This draft...
by Allison Kavanagh | Dec 5, 2024 | News, Press Releases
WASHINGTON, D.C., DECEMBER 4, 2024 – With only 27 days remaining until telehealth flexibilities are set to expire, the American Telemedicine Association (ATA) and ATA Action continue to urge Congress to extend access to critically-needed virtual care services in a...
by Brian Cardillo | Nov 16, 2024 | News, Press Releases
WASHINGTON, D.C. NOVEMBER 15, 2024 – This afternoon, a third extension was officially posted to the Federal Register, granting the U.S. Drug Enforcement Administration (DEA) a clean, one-year extension of the remote prescribing of controlled substances. This critical...